The goal of the Hematology/Oncology Fellowship Program is to train leaders in oncology. We recognize that these leaders may achieve in a diverse range of domains, including cancer prevention, health policy, clinical care, patient-based translational research and basic science. With world class laboratory and clinical research faculty, renowned expert clinicians and a patient base that is unmatched anywhere else in the world, we are uniquely positioned to train a new generation of experts in each of these areas.
Our fellows are given the structure and supervision required to ensure that each is a well-trained, competent oncologist, and given the protected time required to build the beginnings of an academic career. Ultimately, our success is judged by the ability of each fellow to excel in their own defined professional goals.
We offer a fully integrated, three-year hematology and medical oncology program. The first 18 months of training incorporates 12 months of clinical rotation, which includes both solid tumors and hematologic malignancies with 6 months of benign hematology. The ACGME core competencies and milestones are achieved through a required set of rotations, a didactic curriculum and elective rotations designed to broaden the base of knowledge.
Our fellows, faculty, and program are continuously evaluated to ensure success in achieving these competencies, goals and objectives. For the remaining 18 months, the fellow is also involved in the clinical research program of each service or section and is encouraged to develop a research program of his/her own and to compete for national presentations and awards. Achievements.
Educational tracks have been developed for clarifying the expected clinical and research expectations of each fellow. All fellows must declare a training track at the beginning of their second year. There are common elements which apply to all tracks:
Following fellowship training, fellows may compete for entry into the Division of Cancer Medicine Advanced Scholar Program. This program provides for 100% protected time to concentrate their efforts intensively in an area of investigation and practice started in the fellowship program. Completion of the Advanced Scholar Program positions each scholar for success in a tenure-track position in academic medicine.
How to Apply
ERAS opens for new applications on July 1, 2016. Deadline for submission of applications for the 2017 Academic Year will be Aug. 31, 2016. Interviews will be conducted Sept. 10-Oct. 29, 2016.
Applications are accepted through the Electronic Residency Application System (ERAS) only.
Required documents for all applicants:
- Curricula vitae
- Personal statement
- USMLE or COMLEX transcript
- (3) Letters of recommendation, plus
- (1) Letter of recommendation from your program director
- Medical school transcript
- Photograph (optional)
Catherine Butler-Gunn, J.D.
Division of Cancer Medicine GME Programs
Division of Cancer Medicine
UT MD Anderson Cancer Center
1400 Holcombe Blvd., Unit 463
Houston, TX 77030
MD Anderson Cancer Center is committed to encouraging good health and staying true to our mission to end cancer. If you are applying for a GME fellowship or residency program starting on or after July 1, 2016, please be advised that MD Anderson will have instituted a tobacco-free hiring process as part of its efforts to achieve these goals. If you are offered an appointment, you will be subject to a Pre-Employment Drug Screen for tobacco compounds in compliance with applicable state laws. If you do not pass the urine drug screening which includes testing for tobacco compounds, you CANNOT be appointed at MD Anderson. Should you fail to meet this contingency, MD Anderson will withdraw your offer of appointment for the academic year. You may reapply for the following academic year, but there are no guarantees that you will be offered a position as many of our programs are already filled for several years out.